NEWTOWN, Pa., Aug. 6, 2021 /PRNewswire/ — Company Contact:Name: Susan DiCrocePhone Number: (215) 579-1842 Ext: 1260 KVK Tech, Inc., is voluntarily recalling two lots of Atovaquone Oral Suspension, USP 750 mg/5mL to the consumer level. The recall is based on customer complaints of unusual grittiness in the product, which KVK has determined was most probably caused by prolonged exposure… Read more »
Posts By: admin
Regulatory Associate
KVK Tech is looking for a Regulatory Associate to join our team in Newtown PA. This position’s responsibilities will include, but not be limited to the following: Benefits Include: 401(k) with matching Health, Vision, Dental Insurance Childcare Scholarship Tuition Reimbursement Bonus Pay + Merit Increases Paid Time Off Flexible Holidays We are looking for applicants… Read more »
Press Release
The allegations attributed to KVK are without merit, and we intend to vigorously defend our company and its good name as this process moves forward. We will not comment further other than to say that the allegations relate to events that occurred a decade ago and at no time ever implicated product quality or patient… Read more »
Packaging Operator 2nd Shift
KVK Tech is looking for Packaging Operators to join our team in Newtown PA. This position’s responsibilities will include, but not be limited to the following: Handle start up and shut down duties pertaining to the packaging equipment at the beginning and end of each shift. Operate packaging equipment in accordance with all company SOPs,… Read more »
KVK is immensely proud of the dedication of our essential employees
At KVK, we realize that all that stands between the American public and a dangerous shortage of prescription medication are the men and women that make up the pharmaceutical industry. If these unsung-heroes do not make it to work, patients face dangerous drug shortages. KVK is immensely proud of the dedication of our essential employees…. Read more »
1-2-3 Savings Program for Lomaira™
KVK Tech, Inc. Announces 1-2-3 Savings Program for Lomaira™ (phentermine hydrochloride USP) 8 mg Tablets, CIV Cost Savings for Lomaira Patients NEWTOWN, PA., May 2, 2018 /PRNewswire/ — KVK Tech, Inc. (KVK), a leading American developer, manufacturer, and marketer of FDA-approved pharmaceuticals today announced the LOMAIRA 1-2-3 program. The 1-2-3 program allows patients to start… Read more »
KVK Tech, Inc. Announces Partnership with Medix for International Expansion into Mexico.
KVK Tech, Inc. Announces Partnership with Medix for International Expansion into Mexico. NEWTOWN, PA., Nov 14, 2017 /PRNewswire/ — KVK Tech, Inc. (KVK), a leading American developer, manufacturer, and marketer of FDA-approved pharmaceuticals today announced a strategic partnership with Productos Medix S.A. de C.V. (“Medix”), a leader in pharmaceutical obesity products in Mexico. The licensing… Read more »
KVK Tech Announces FDA-Approval of Lomaira™
KVK Tech Announces FDA-Approval of Lomaira™ (phentermine hydrochloride USP) 8 mg tablets, CIV, A Low-Cost, Low-Dose Phentermine That Can Be Used Up to Three Times Daily for Weight Reduction Newtown, PA, Sept. 20, 2016 — KVK Tech, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Lomaira™ (phentermine hydrochloride USP) 8… Read more »
Recent Comments